Key result
Continuous epidural infusion of bupivacaine provided significantly better preservation of forced vital capacity and lower pain scores on movement compared to intermittent boluses following renal surgery.
Why the study?
Does continuous epidural infusion of bupivacaine improve postoperative analgesia compared to intermittent boluses in patients undergoing elective renal surgery?
Population
60 patients of either sex, ASA class I or II, scheduled to undergo elective renal surgery
Comparison
Continuous epidural infusion of 0.166% bupivacaine vs Intermittent boluses of bupivacaine through…
Design
RCT, randomised manner
Follow-up
up to 12 hours
Authors
Loading...
Continuous infusion warrants preference in renal surgery protocols for optimized recovery; extends RCT evidence on epidural delivery to this population.
RCT (n=60)
Randomized
No
Does continuous epidural infusion of bupivacaine improve postoperative analgesia compared to intermittent boluses in patients undergoing elective renal surgery?
Absolute Event Rate: 2.16% vs 1.12%
p-value: p=<0.05
Continuous epidural infusion of bupivacaine provides better postoperative analgesia and preserves pulmonary function better than intermittent boluses following renal surgery.
Virmani et al. (2008) conducted an RCT in Postoperative pain following renal surgery (n=60). Continuous epidural infusion of bupivacaine vs. Intermittent epidural boluses of 15 ml of 0.166% bupivacaine three-hourly was evaluated on Forced vital capacity (FVC) in liters at 3 hours postoperatively (p=<0.05). Continuous epidural infusion of bupivacaine provided significantly better preservation of forced vital capacity and lower pain scores on movement compared to intermittent boluses following renal surgery.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: